Drug intelligence / Profile preview

liuwei dihuang wan (Huiren Group)

Development stage
Unknown
Lead developer
Jiangxi Huiren Pharmaceutical
Administration
Oral
01

Overview

Huiren Liuwei Dihuang Wan is a traditional Chinese medicine (TCM) product developed and manufactured by Huiren Group. It is a classic formula consisting of six herbal ingredients: prepared Rehmannia root, Asiatic cornelian cherry fruit, Chinese yam, Oriental water plantain rhizome, Poria, and Tree peony bark. In TCM theory, it is primarily used to nourish kidney yin and treat symptoms associated with kidney yin deficiency, such as dizziness, tinnitus, soreness and weakness of the waist and knees, night sweats, and hot flashes. It is one of the most widely used TCM formulas in China for general health maintenance and chronic conditions related to aging and metabolic health.

Brand names
HuirenHuiren Liuwei Dihuang Wan
Other names
汇仁牌六味地黄丸Six-Ingredient Pill with Rehmannia
02

Targets

JUN (Transcription factor Jun)ADORA2A (Adenosine A₂A Receptor)VEGFA (Vascular endothelial growth factor A)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)

Beyond the preview

Go deeper on liuwei dihuang wan (Huiren Group).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on liuwei dihuang wan (Huiren Group).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call